Trial intelligence / Profile preview

Paracetamol timing during hepatitis B vaccination and antibody response

NL-OMON36173Withdrawn

Sponsor
National Institute for Public Health and the Environment
Start
Mar 2011
Modality
Small Molecules, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of acetaminophen and Hepatitis B vaccine in hepatitis B (HBV) (4 arms), sponsored by National Institute for Public Health and the Environment. Planned start Mar 2011; status: withdrawn.

02

Drugs

acetaminophenHepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NL-OMON36173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call